Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT01390818 · COMPLETED

Trial details

NCT number: NCT01390818
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Solid Tumor Breast Cancer Non Small Cell Lung Cancer Melanoma Colorectal Cancer

Start date: 2011-05-01
Primary completion: 2015-04-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.